NEWS COMMENTARY

Impossible Foods raises $200 million Series G round, bringing total funding to $1.5 billion

Published:
August 17, 2020
Coverage:
Emerging Ecosystems in Agrifood and Health More...
Activities:
Investment
Very important

New investor Coatue led the round, which comes only four months after Impossible raised a $500 million Series F round. Major company updates include over 60× retail footprint expansion in the U.S., increased presence of Impossible Sausage up to 22,000 restaurants, and new items in its R&D pipeline. The latter is particularly intriguing, with the company stating that it is currently working on new products ranging from plant-based milk to steak. If the company continues to use fermentation-derived ingredients in its formulations, much like it does today with heme, it will be another vote of confidence in the approach for reaching sensorial parity in plant-based foods.

For the original news article, click here .


Further Reading

Perfect Day rakes in $140 million Series C round led by Temasek, bringing total funding to more than $200 million

News Commentary | December 13, 2019

The funding comes just a few weeks after the company announced it is expanding into dairy fats. While this event is a win for cellular agriculture, it underscores the capital‑intensive nature of scaling the production approach. As a reference, the most highly funded plant‑based dairy company, Ripple... Not part of subscription

Biotalys gains additional $11.3 million for its Series C

News Commentary | March 09, 2020

Ghent‑based Biotalys has announced the second closing of its Series C, raising an additional $11.3 million for a total amount of $50.8 million. The latest capital is joined by current shareholders and Novalis LifeSciences. This news also follows Biotalys' partnership with Chrysal to explore ... Not part of subscription

Mycoproteins gain funding momentum as The Protein Brewery raises $22 million Series A

News Commentary | November 12, 2020

This Series A round was led by Novo Holdings, joined by Roquette Ventures and Unovis Asset Management, and will help the Dutch startup to focus on R&D as well as scale up production of its mycoprotein ingredient "Fermotein." It hopes to commercialize Fermotein upon regulatory approval by 2021 in... To read more, click here.